Constructive news tone
News Sentiment
HCM sentiment intelligence
HUTCHMED DRC news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Constructive headlines are not being rewarded by price, which raises a rejection flag.
73/100 classification confidence.
directly relevant articles
high-authority source matches
-3.2% over one week, +1.0% over four weeks, trend inactive, and below fair value.
HUTCHMED (China) Ltd (HCM) Shares Surge 3.0% -- What GF Score of 79 Tells Investors
Market Reaction
Positive news being faded
Constructive headlines are not being rewarded by price, which raises a rejection flag.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Why HUTCHMED (China) Limited (HCM) Is Gaining Attention After China Biotech Re-Rating
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Market source
Hutchmed stock hits 52-week low at 11.7 USD
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 07:00
- Source
- Investing.com
Innovent and HUTCHMED Jointly Announce NMPA Approval for TYVYT® (Sintilimab Injection) in Combination with ELUNATE® (Fruquintinib) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 21 May 2026 10:00
- Source
- PR Newswire
HUTCHMED and Innovent Jointly Announce NMPA Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 21 May 2026 10:00
- Source
- GlobeNewswire
HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Apr 2026 10:00
- Source
- GlobeNewswire